Congenica Expands its Clinical Consulting Services

Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the expansion of its range of clinical consulting services. In addition to the services  already offered by Congenica, the Company has launched a new “sample to report” service, providing additional access to sequence [...]

Lightsense Technology and Pure Norwegian Seafood Join Forces to Develop Solutions for Detection of Bacterial Pathogens in Salmon Processing

Enables newest technology to protect food supply chain and help marine aquaculture Tucson, Arizona – Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the Covid-19 pandemic, as well as food safety and quality assurance in the food supply chain—announced today a new partnership with a leader [...]

Protein Metrics Deepen Collaboration in Liquid Chromatography-Mass Spectrometry and Biotherapeutic Characterization Workflows with Agilent Technologies

CUPERTINO, Calif. -- Protein Metrics Inc announced the continuation of the productive partnership with Agilent Technologies, Inc. that has helped to integrate information from their common customers. The companies have entered into an agreement that allows Agilent to sell the Byos® software with their Liquid Chromatography-Mass Spectrometry (LC-MS) systems and work on common applications areas of interest. [...]

DISCNGINE PARTNERS UP WITH CHEMAXON TO ENHANCE ITS 3DECISION® PLATFORM FOR INNOVATIVE STRUCTURE-DRIVEN DRUG DISCOVERY

Discngine, a research and lab informatics software and services company, announces a strategic partnership with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, the partners expect to streamline pharma and biotech research involving complex biomolecular structural data. Paris --Discngine’s 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base. Its fundamental value [...]

Biognosys Announces GLP Certification of its Proteomics Facility by the Swiss Health Authorities

Biognosys is the first global proteomics service provider that is GLP certified for preclinical studies and GCP compliant for clinical studies ZURICH – Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that it has obtained Good Laboratory Practice (GLP) certification from Swiss health authorities for preclinical studies. With this certification, [...]

Covaris Announces Growth Partnership with New Mountain Capital

Strategic Investment to Drive Accelerated Growth WOBURN, Mass. & NEW YORK -- Covaris, Inc. ("Covaris" or "the Company"), a manufacturer of advanced tools enabling life science innovations, announced today that New Mountain Capital ("New Mountain"), a leading growth-oriented investment firm with over $35 billion in assets under management, has made a majority investment in the [...]

PacBio Names Lara Toerien as Vice President and General Manager for the Americas

MENLO PARK, Calif. -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible for leading and developing PacBio’s commercial organization within North and South America while furthering its growth and market presence throughout the [...]

Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System

Powered by novel technology that can map a million cells in 10 minutes, the system enables unbiased spatial discovery across whole slides, at scale MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the commercial availability of the PhenoCycler™-Fusion system, setting a new standard in spatial biology for high-speed imaging [...]

BICO Partners with the Center for Contemporary Sciences to Reduce Animal Testing in Life Sciences

The two organizations will work closely to build support for the bipartisan FDA Modernization Act and reduce animal testing by promoting human-specific medical research technologies that include advanced in-vitro tissue models and 3D bioprinting. Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary Sciences (CCS), a research and advocacy [...]

Game changing drug screening program launched with DART-MS technology

Saugus, MA - IonSense,  the leading provider of Direct analysis in real time mass spectrometry (DART) for rapid mass spectral analysis of a large variety of samples, has announced its ground-breaking DART-MS technology has been selected as part of a new drug screening program, piloting in five states across the United States. The pilot program is [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access

Register to Subscribe Login for Access

Lost your password? Register